Michael Reilly, Esq., is the Executive Director of the Alliance for Safe Biologic Medicines (ASBM) who have been leading education and advocacy efforts on all issues related to biosimilars since 2010. ASBM is an organization of patients, physicians, pharmacists and biotechnology companies working to ensure that patient safety is at the forefront of the biosimilars policy discussion. In that capacity Mr. Reilly has co-authored several white papers on biosimilars and presented at the DIA Conferences in Dublin and Berlin, appeared before the World Health Organization and released ASBM physician survey data to the Spanish Health Ministry in Madrid and the Italian Ministry of Health in Rome. Previously, Mr. Reilly served as the Associate Deputy Secretary at the U.S. Department of Health and Human Services (HHS) from 2005-2008 responsible for policy development and implementation, as well as regulatory oversight for issues involving the Center for Medicare and Medicaid Services (CMS) and the Food and Drug Administration (FDA). In addition, Mr. Reilly served as a senior advisor to the Assistant Secretary for Public Affairs and the Assistant Secretary for Planning and Evaluation at HHS from 2002-2005. Mr. Reilly has more than a decade of experience in the federal government developing and implementing healthcare policy in the legislative and executive branches.